Dataset Information


Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909.

ABSTRACT: T cells with specificity for antigens derived from Wilms Tumor gene (WT1), Proteinase3 (Pr3), and mucin1 (MUC1) have been demonstrated to lyse acute myeloid leukemia (AML) blasts and multiple-myeloma (MM) cells, and strategies to enhance or induce such tumor-specific T cells by vaccination are currently being explored in multiple clinical trials. To test safety and immunogenicity of a vaccine composed of WT1-, Pr3-, and MUC1-derived Class I-restricted peptides and the pan HLA-DR T helper cell epitope (PADRE) or MUC1-helper epitopes in combination with CpG7909 and MontanideISA51, four patients with AML and five with MM were repetitively vaccinated. No clinical responses were observed. Neither pre-existing nor naive WT1-/Pr3-/MUC1-specific CD8+ T cells expanded in vivo by vaccination. In contrast, a significant decline in vaccine-specific CD8+ T cells was observed. An increase in PADRE-specific CD4+ T helper cells was observed after vaccination but these appeared unable to produce IL2, and CD4+ T cells with a regulatory phenotype increased. Taken into considerations that multiple clinical trials with identical antigens but different adjuvants induced vaccine-specific T cell responses, our data caution that a vaccination with leukemia-associated antigens can be detrimental when combined with MontanideISA51 and CpG7909. Reflecting the time-consuming efforts of clinical trials and the fact that 1/3 of ongoing peptide vaccination trails use CpG and/or Montanide, our data need to be taken into consideration.


PROVIDER: S-EPMC3024516 | BioStudies | 2011-01-01

REPOSITORIES: biostudies

Similar Datasets

2012-01-01 | S-EPMC4163946 | BioStudies
2011-01-01 | S-EPMC3032008 | BioStudies
2015-01-01 | S-EPMC4617516 | BioStudies
2008-01-01 | S-EPMC3066096 | BioStudies
1000-01-01 | S-EPMC3252914 | BioStudies
2010-01-01 | S-EPMC2922237 | BioStudies
2017-01-01 | S-EPMC5383632 | BioStudies
1000-01-01 | S-EPMC4589057 | BioStudies
2008-01-01 | S-EPMC2574650 | BioStudies
2011-01-01 | S-EPMC3046275 | BioStudies